Bethyl Laboratories
Rabbit anti-IMP3 Recombinant Monoclonal Antibody [BLGR051]New
Primary
Catalog #A701-051
TargetIMP3
HostRabbit
CloneBLGR051
ReactivityHuman
ApplicationIHC
Image 1 of 1
local_shipping
This item has an estimated lead time of two weeks.
Product Description
Insulin-like growth factor 2 mRNA-binding protein 3 (IMP3) is an RNA-binding protein that act as a regulator of mRNA translation and stability. IMP3 binds to the 5'-UTR of the insulin-like growth factor 2 (IGF2) mRNAs and to sequences in the 3'-UTR of CD44 mRNA [taken from the Universal Protein Resource (UniProt) www.uniprot.org/uniprot/ O00425].
Specifications
Clonality
Recombinant Monoclonal
Clone
BLGR051
Host
Rabbit
Isotype
IgG
Reactivity
Human
Format
Whole IgG
Conjugate Type
Unconjugated
Purity
Purified
Target Identity
TargetIMP3
Antigen Species
Human
Gene ID10643
Gene Symbol
IGF2BP3
Gene Name
insulin like growth factor 2 mRNA binding protein 3
Uniprot IDO00425
Protein Name
Insulin-like growth factor 2 mRNA-binding protein 3
Alternate Names
cancer/testis antigen 98 • CT98 • hKOC • IGF2 mRNA-binding protein 3 • IGF-II mRNA-binding protein 3 • IMP3 • IMP-3 • insulin-like growth factor 2 mRNA-binding protein 3 • KH domain containing protein overexpressed in cancer • KH domain-containing protein overexpressed in cancer • KOC • KOC1 • VICKZ family member 3 • VICKZ3
Product Information
Applications
IHC
Buffer
Tris-buffered Saline with 1% BSA and <0.1% Sodium Azide
Storage Conditions
2 - 8 °C
Physical State
Liquid
Shelf Life
1 year from date of receipt
Country of Origin
USA
Applications
Immunohistochemistry (IHC)1:25 to 1:100
Documents
Product DatasheetPDF · A701-051 · Lot 1 (current lot)Open
Product DatasheetPDF · A701-051 · Lot 1 (current lot)Open
Safety Data SheetPDF · A701-051Open
Services
Antibody Conjugation
Antibody and conjugate formats developed together, built to your specification.
Request CustomizationCustom Monoclonal Antibody Discovery Services
Full custom monoclonal development, from immunization through validation.
Explore Monoclonal DevelopmentVHH Discovery
Single-domain antibodies for structurally difficult targets a conventional monoclonal can't reach.
Explore VHH DiscoveryResources
1